1397TiP Phase III trial of the therapeutic cancer vaccine OSE2101 versus docetaxel in patients with metastatic non-small cell lung cancer and secondary resistance to immunotherapy.

Authors :: Liu, S.V.
Dziadziuszko, R.
Viteri, S.
Cappuzzo, F.
Comis, S.
Gabarre, V.
Chevalier, C.
Vandewalle, T.
Montestruc, F.
Vasseur, B.
Remon Masip, J.
Besse, B.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS874-S875. 2p.
Publication Year :: 2024

Subjects :: *CLINICAL trials
*NON-small-cell lung carcinoma
*CANCER vaccines
*DOCETAXEL
*IMMUNOTHERAPY

Full Text Access

Tools